QA: Design Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001807120_2023_Design_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001807120, Design Therapeutics Inc.

  xvar xval
0 AssetsCurrent 335,119,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,947,000
3 remainder_Assets 4,071,000
4 LiabilitiesCurrent 10,776,000
5 LiabilitiesNoncurrent 3,051,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 18,980,000
9 ResearchAndDevelopmentExpense 48,613,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 4,285,000
13 remainder_ComprehensiveNetIncome -3,112,000
  yvar yval
0 Assets 341,137,000
1 Liabilities 13,827,000
2 Expenses 67,593,000
3 Revenues 0
4 StockholdersEquity 327,310,000
5 NetIncome -63,308,000
6 ComprehensiveNetIncome -64,864,000
7 BaseVar 214,977,000
8 EconomicCapitalRatio 2.81

Edgar->Model Mapping

Feature Distribution

Change over Time